Sharon H. Hrynkow Ph.D.
Net Worth
Last updated:
What is Sharon H. Hrynkow Ph.D. net worth?
The estimated net worth of Dr. Sharon H. Hrynkow Ph.D. is at least $1,503,244 as of 2 Dec 2021. He owns shares worth $13,944 as insider and has received compensation worth at least $1,489,300 in Cyclo Therapeutics, Inc..
What is the salary of Sharon H. Hrynkow Ph.D.?
Dr. Sharon H. Hrynkow Ph.D. salary is $297,860 per year as Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Senior Vice President of Medical Affairs in Cyclo Therapeutics, Inc..
How old is Sharon H. Hrynkow Ph.D.?
Dr. Sharon H. Hrynkow Ph.D. is 65 years old, born in 1960.
What stocks does Sharon H. Hrynkow Ph.D. currently own?
As insider, Dr. Sharon H. Hrynkow Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cyclo Therapeutics, Inc. (CYTH) | Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Senior Vice President of Medical Affairs | 19,350 | $0.72 | $13,944 |
What does Cyclo Therapeutics, Inc. do?
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Sharon H. Hrynkow Ph.D. insider trading
Cyclo Therapeutics key executives
Cyclo Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Jeffrey L. Tate (67) Chief Operating Officer, Chief Quality Officer & Director
- Dr. Sharon H. Hrynkow Ph.D. (65) Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Senior Vice President of Medical Affairs
- Mr. N. Scott Fine (68) Chief Executive Officer & Director